Original Research

Published on 24 Jun 2024

Genomic modifications for enhanced antibiotic production in rifamycin derivative-producing Amycolatopsis mediterranei S699 strains: focusing on rifQ and rifO genes

in Antibiotic Development

Moritz Müller
Elena Bialas
Irina Sturm
Utkarsh Sood
Rup Lal
Andreas Bechthold

Frontiers in Antibiotics

doi 10.3389/frabi.2024.1399139

1,034 views

Original Research

Published on 08 May 2024

Mycobactin analogue interacting with siderophore efflux-pump protein: insights from molecular dynamics simulations and whole-cell assays

in Antibiotic Development

Mousumi Shyam
Abhishek Thakur
Caroline Velez
Chris Daniel
Orlando Acevedo
Sanjib Bhakta
Venkatesan Jayaprakash

Frontiers in Antibiotics

doi 10.3389/frabi.2024.1362516

1,481 views

Original Research

Published on 08 Apr 2024

Targeting synthesis of the Chromosome Replication Initiator Protein DnaA by antisense PNA-peptide conjugates in Escherichia coli

in Antibiotic Development

Christopher Campion
Godefroid Charbon
Peter E. Nielsen
Anders Løbner-Olesen

Frontiers in Antibiotics

doi 10.3389/frabi.2024.1384390

1,016 views

Original Research

Published on 21 Aug 2023

Gold complex compounds that inhibit drug-resistant Staphylococcus aureus by targeting thioredoxin reductase

in Antibiotic Development

Nagendran Tharmalingam
Shi Xu
Lewis Oscar Felix
Biswajit Roy
Ming Xian
Eleftherios Mylonakis
Beth Burgwyn Fuchs

Frontiers in Antibiotics

doi 10.3389/frabi.2023.1179354

1,848 views
1 citation

Original Research

Published on 17 Jul 2023

Nanotherapeutic delivery of antibiotic cocktail enhances intra-macrophage killing of Mycobacterium marinum

in Antibiotic Development

Andrea M. Binnebose
Adam S. Mullis
Shannon L. Haughney
Balaji Narasimhan
Bryan H. Bellaire

Frontiers in Antibiotics

doi 10.3389/frabi.2023.1162941

1,096 views

Original Research

Published on 12 Jul 2023

Screening Amazon rainforest plant extracts for antimicrobial activity: a 15-year commitment to the Brazilian biodiversity

in Antibiotic Development

Ivana Barbosa Suffredini
Jefferson de Souza Silva
Sergio Alexandre Frana
Katia Cristina Pinto
Keli Cristina Dias Bento
Erika Costa Rudiger
Paloma Kelly de Souza Belo
José Rodrigo de Arruda
Juliana Paola Schulze
Adriana Lígia de Castilho

Frontiers in Antibiotics

doi 10.3389/frabi.2023.1122400

2,969 views
1 citation

Brief Research Report

Published on 22 Mar 2023

Antimicrobial activity of a new class of synthetic retinoid antibiotics and comparator agents against ocular staphylococci

in Antibiotic Development

Camille André
Cassandra L. Schrank
Ana Victoria Cheng Jaramillo
Eleftherios Mylonakis
William M. Wuest
Michael S. Gilmore
Wooseong Kim
Paulo J. M. Bispo

Frontiers in Antibiotics

doi 10.3389/frabi.2023.1101450

1,389 views

Review

Published on 09 Feb 2023

Repurposing inhibitors of phosphoinositide 3-kinase as adjuvant therapeutics for bacterial infections

in Antibiotic Development

Renee Fleeman

Frontiers in Antibiotics

doi 10.3389/frabi.2023.1135485

1,385 views
3 citations

Mini Review

Published on 30 Jan 2023

Resistance-resistant antibacterial treatment strategies

in Antibiotic Development

Jonathan I. Batchelder
Patricia J. Hare
Wendy W. K. Mok

Frontiers in Antibiotics

doi 10.3389/frabi.2023.1093156

4,555 views
4 citations

Original Research

Published on 09 Sep 2022

Implications of drug-induced phenotypical resistance: Is isoniazid radicalizing M. tuberculosis?

in Antibiotic Development

RJH Hammond
Frank Kloprogge
O. Della Pasqua
Stephen H. Gillespie

Frontiers in Antibiotics

doi 10.3389/frabi.2022.928365

1,414 views
1 citation

Navigation group

Articles

Genomic modifications for enhanced antibiotic production in rifamycin derivative-producing Amycolatopsis mediterranei S699 strains: focusing on rifQ and rifO genes

Mycobactin analogue interacting with siderophore efflux-pump protein: insights from molecular dynamics simulations and whole-cell assays

Targeting synthesis of the Chromosome Replication Initiator Protein DnaA by antisense PNA-peptide conjugates in Escherichia coli

Gold complex compounds that inhibit drug-resistant Staphylococcus aureus by targeting thioredoxin reductase

Nanotherapeutic delivery of antibiotic cocktail enhances intra-macrophage killing of Mycobacterium marinum

Screening Amazon rainforest plant extracts for antimicrobial activity: a 15-year commitment to the Brazilian biodiversity

Antimicrobial activity of a new class of synthetic retinoid antibiotics and comparator agents against ocular staphylococci

Repurposing inhibitors of phosphoinositide 3-kinase as adjuvant therapeutics for bacterial infections

Resistance-resistant antibacterial treatment strategies

Implications of drug-induced phenotypical resistance: Is isoniazid radicalizing M. tuberculosis?